10a-Azalide compound crosslinked at 10a- and 12-positions
US8293715B2 · kind B2 · utility
0Cited by
7References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 6, 2008 |
| Grant date | Oct 23, 2012 |
| Priority date | — |
| Expiry date | Feb 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel 10a-azalide compound crosslinked at the 10a- and 12-positions, which is represented by the following formula, and is effective on even Hemophilus influenzae, or erythromycin resistant bacteria (e.g., resistant pneumococci and streptococci).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.